AzurRx BioPharma, Inc.·4

Jan 2, 5:55 PM ET

Riddell Alastair 4

4 · AzurRx BioPharma, Inc. · Filed Jan 2, 2019

Insider Transaction Report

Form 4
Period: 2018-12-28
Transactions
  • Award

    Common Stock

    2018-12-28$1.29/sh+7,500$9,67570,000 total
Footnotes (1)
  • [F1]Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018.

Documents

1 file
  • 4
    form4-01022019_020116.xmlPrimary